Clinical Trial Update: Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating chloroquine as an anti-autophagic radiosensitizer in stage I-III small cell lung cancer; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Chloroquine (chloroquine)

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Small Cell Lung Cancer | Phase 1 | Status: TERMINATED